SCHEMBL6728306

SCHEMBL6728306

CCC1CCCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486887 0.97
SCHEMBL153432 0.97
SCHEMBL13486886 0.97
SCHEMBL7561464 0.95
SCHEMBL178378 0.90
SCHEMBL12840 0.90
SCHEMBL170737 0.90
Fluoride SCHEMBL28553579 0.87 KMT2A (0.39)
Ammonia Solution, Strong SCHEMBL27597475 0.87
SCHEMBL28381148 0.83 KMT2A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109155365-B Polyanionic copolymers of conductive polymers for use in solid electrolytic capacitors 凯米特电子公司 2022-12-13 CN disclosed
CN-109535707-A Pneumatic tire 横滨橡胶株式会社 2019-03-29 CN disclosed
CN-104125982-B Thermoplastic resin composition and the tire using which 横滨橡胶株式会社 2017-03-15 CN disclosed
US-9393239-B2 Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2016-07-19 US disclosed
US-9127044-B2 Cyclic depsipeptides NOVARTIS AG (CH) 2015-09-08 US disclosed
US-20140221341-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETALACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (CA) 2014-08-07 US disclosed
US-20130172267-A1 USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 NOVARTIS AG (CH) 2013-07-04 US disclosed
US-8455471-B2 Compositions of CHK1 inhibitors and cyclodextrin ICOS CORPORATION (US) 2013-06-04 US disclosed
US-8415305-B2 Use of cyclic depsipeptides to inhibit kallikrein 7 NOVARTIS AG (CH) 2013-04-09 US disclosed
US-20130060020-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20130060021-A1 Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-20120196790-A1 CYCLIC DEPSIPEPTIDES NOVARTIS AG (CH) 2012-08-02 US disclosed
US-8178650-B2 Cyclic depsipeptides NOVARTIS AG (CH) 2012-05-15 US disclosed
US-20120034650-A1 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof NOVARTIS AG (CH) 2012-02-09 US disclosed
US-20110092437-A1 USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 NOVARTIS AG (CH) 2011-04-21 US disclosed
US-20100022512-A1 COMPOSITIONS OF CHK1 INHIBITORS AND CYCLODEXTRIN WISDOM WENDY A 2010-01-28 US disclosed
US-20090156472-A1 Cyclic Depsipeptides NOVARTIS AG (CH) 2009-06-18 US disclosed